CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00723112
NCT00723112N/ACompleted
CompareCT.gov

The Role of Erythropoietin in Myelodysplastic Syndrome

University of Utah·observational·Posted Jul 28, 2008·Updated Nov 23, 2010

In Brief

An observational study for Myelodysplastic Syndrome. Completed, enrolled 8 participants across 2 sites.

Detailed Summary

The purpose of the study is to elucidate the causative molecular events responsible for the abnormal erythropoiesis in MDS.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyelodysplastic Syndrome
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 28, 2008
Enrollment StartFeb 1, 2007
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 17.9 years ago